Affiliation: Academic Medical Center
Country: The Netherlands
- A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolismA Kleinjan
A Kleinjan, MD, Department of Vascular Medicine, Room F4 147, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands, Tel 31 20 5665975, Fax 31 20 5669343, E mail
Thromb Haemost 110:959-65. 2013..In contrast, the dose of LMWH and the type of anticoagulant chosen after the initial 3-12 months varied substantially, probably reflecting the limited available evidence. ..
- Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective studyFrederiek van Doormaal
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Thromb Haemost 108:160-5. 2012..However, in the patients who developed VTE within six months when compared to those who did not, an increased MP procoagulant activity was present already at baseline, suggesting this activity can be used to predict VTE...
- Limitations of screening for occult cancer in patients with idiopathic venous thromboembolismA Kleinjan
Department of Vascular Medicine, Academic Medical Center in Amsterdam, Amsterdam, The Netherlands
Neth J Med 70:311-7. 2012..Here, the costs and test characteristics of these screening strategies are presented, including true- and false-positive findings, sensitivity and specificity...
- Cell-derived microvesicles and cancerF F van Doormaal
Departments of Vascular Medicine and Clinical Chemistry, Academic Medical Centre, Amsterdam, The Netherlands
Neth J Med 67:266-73. 2009..Here, we will present an overview of the many contributions of microvesicles to cancer development and progression. In addition, their role in risk stratification and treatment of cancer patients is discussed...